Difference between revisions of "Elijah Odoyo-June"
m (using ABBR section) |
(using Template:Population-based studies) |
||
| (5 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
| − | '''{{FULLPAGENAME}}''' is member of the 2018 Guideline Development Group (GDG) of the [[WHO]]. The GDG's task is to develop updated recommendations on safe male circumcision for HIV prevention and related service delivery for adolescent boys and men in generalized HIV epidemics.<ref>{{REFweb | + | '''{{FULLPAGENAME}}''' is member of the 2018 Guideline Development Group (GDG) of the [[WHO]]. The GDG's task is to develop updated recommendations on safe male circumcision for [[HIV]] prevention and related service delivery for adolescent boys and men in generalized [[HIV]] epidemics.<ref>{{REFweb |
|url=https://www.who.int/hiv/mediacentre/news/gdg-male-circumcision/en/ | |url=https://www.who.int/hiv/mediacentre/news/gdg-male-circumcision/en/ | ||
|title=WHO to develop new guidelines on male circumcision | |title=WHO to develop new guidelines on male circumcision | ||
| Line 11: | Line 11: | ||
<blockquote>'''Odoyo-June, Elijah''' | <blockquote>'''Odoyo-June, Elijah''' | ||
* US Centers for Disease Control and Prevention (CDC), Kenya | * US Centers for Disease Control and Prevention (CDC), Kenya | ||
| − | * | + | * {{MBChB}}, {{MS}}, {{PhD}} |
* Nairobi, Kenya | * Nairobi, Kenya | ||
| − | Elijah Odoyo-June is a medical doctor with postgraduate training in public health and a {{PhD}} in Tropical and infectious Diseases. He has over 20 years of progressive responsibilities in clinical and preventive health care including research experience in the fields of Reproductive health, HIV/AIDS, health systems development in Kenya and Malawi. His recent research experiences in male circumcision include coordination of long term follow up of clients enrolled in the Randomized controlled trial of Male Circumcision for HIV prevention in Kisumu Kenya, study of wound healing following medical circumcision of HIV +ve and HIV-ve adult males in Kisumu; safety and acceptability of Early Infant Male circumcision in Kisumu, study of effectiveness and safety of [[Prepex|PrePex]] for circumcision in Kenya and active AE surveillance for ShangRing circumcision. | + | Elijah Odoyo-June is a medical doctor with postgraduate training in public health and a {{PhD}} in Tropical and infectious Diseases. He has over 20 years of progressive responsibilities in clinical and preventive health care including research experience in the fields of Reproductive health, [[HIV]]/[[AIDS]], health systems development in Kenya and Malawi. His recent research experiences in male circumcision include coordination of long term follow up of clients enrolled in the Randomized controlled trial of Male Circumcision for [[HIV]] prevention in Kisumu Kenya, study of wound healing following medical circumcision of [[HIV]]+ve and [[HIV]]-ve adult males in Kisumu; safety and acceptability of Early Infant Male circumcision in Kisumu, study of effectiveness and safety of [[Prepex|PrePex]] for [[circumcision]] in Kenya and active AE surveillance for ShangRing circumcision. |
He currently serves as technical lead for [[CDC]]/[[PEPFAR]] supported Medical Male circumcision program in Kenya; providing technical and programmatic guidance for all aspects of [[VMMC]] implementation. As long serving member of Kenya’s national [[VMMC]] TWG he has a rich experience in development of standard operating procedures and guidelines for [[VMMC]] service delivery in Kenya and other African countries.<ref>{{REFdocument | He currently serves as technical lead for [[CDC]]/[[PEPFAR]] supported Medical Male circumcision program in Kenya; providing technical and programmatic guidance for all aspects of [[VMMC]] implementation. As long serving member of Kenya’s national [[VMMC]] TWG he has a rich experience in development of standard operating procedures and guidelines for [[VMMC]] service delivery in Kenya and other African countries.<ref>{{REFdocument | ||
| Line 27: | Line 27: | ||
Odoyo-June is currently employed by the United States Centers for Disease Control and Prevention to actively promote non-therapeutic male circumcision in Africa. PubMed reveals that he is a named author of twenty-one papers, all of which promote non-therapeutic male circumcision in some way. [[Robert C. Bailey]] is a co-author of thirteen of the articles. It would be hard to conceive of a person more biased in favor of non-theapeutic male circumcision. | Odoyo-June is currently employed by the United States Centers for Disease Control and Prevention to actively promote non-therapeutic male circumcision in Africa. PubMed reveals that he is a named author of twenty-one papers, all of which promote non-therapeutic male circumcision in some way. [[Robert C. Bailey]] is a co-author of thirteen of the articles. It would be hard to conceive of a person more biased in favor of non-theapeutic male circumcision. | ||
| + | |||
| + | == Population-based studies == | ||
| + | {{Population-based studies}} | ||
{{SEEALSO}} | {{SEEALSO}} | ||
Latest revision as of 13:21, 21 August 2022
Elijah Odoyo-June is member of the 2018 Guideline Development Group (GDG) of the WHO. The GDG's task is to develop updated recommendations on safe male circumcision for HIV prevention and related service delivery for adolescent boys and men in generalized HIV epidemics.[1]
Biography
The WHO published the following biography of Elijah Odoyo-June:
Odoyo-June, Elijah
- US Centers for Disease Control and Prevention (CDC), Kenya
- MBChB[a 1], M.S.[a 2], Ph.D.[a 3]
- Nairobi, Kenya
Elijah Odoyo-June is a medical doctor with postgraduate training in public health and a Ph.D.[a 3] in Tropical and infectious Diseases. He has over 20 years of progressive responsibilities in clinical and preventive health care including research experience in the fields of Reproductive health, HIV/AIDS, health systems development in Kenya and Malawi. His recent research experiences in male circumcision include coordination of long term follow up of clients enrolled in the Randomized controlled trial of Male Circumcision for HIV prevention in Kisumu Kenya, study of wound healing following medical circumcision of HIV+ve and HIV-ve adult males in Kisumu; safety and acceptability of Early Infant Male circumcision in Kisumu, study of effectiveness and safety of PrePex for circumcision in Kenya and active AE surveillance for ShangRing circumcision.
He currently serves as technical lead for CDC/PEPFAR supported Medical Male circumcision program in Kenya; providing technical and programmatic guidance for all aspects of VMMC implementation. As long serving member of Kenya’s national VMMC TWG he has a rich experience in development of standard operating procedures and guidelines for VMMC service delivery in Kenya and other African countries.[2]
Odoyo-June is currently employed by the United States Centers for Disease Control and Prevention to actively promote non-therapeutic male circumcision in Africa. PubMed reveals that he is a named author of twenty-one papers, all of which promote non-therapeutic male circumcision in some way. Robert C. Bailey is a co-author of thirteen of the articles. It would be hard to conceive of a person more biased in favor of non-theapeutic male circumcision.
Population-based studies
September 2021 saw the publication of two huge population studies on the relationship of circumcision and HIV infection:
- Mayan et al. (2021) carried out a massive empirical study of the male population of the province of Ontario, Canada (569,950 males), of whom 203,588 (35.7%) were circumcised between 1991 and 2017. The study concluded that circumcision status is not related to risk of HIV infection.[3]
- Morten Frisch & Jacob Simonsen (2021) carried out a large scale empirical population study in Denmark of 855,654 males regarding the alleged value of male circumcision in preventing HIV and other sexually transmitted infections in men. They found that circumcised men have a higher rate of STI and HIV infection overall than intact men.[4]
No association between lack of circumcision and risk of HIV infection was found by either study. There now is credible evidence that the massive, expensive African circumcision programs have not been effective in preventing HIV infection.
See also
Abbreviations
- ↑
Bachelor of Medicine, Bachelor of Surgery
, Wikipedia. Retrieved 13 October 2021. (Latin: medicinae baccalaureus, baccalaureus chirurgiae; abbreviated in many ways, most commonly MBBS, but also MB ChB, BMBS, MB BCh, MB BChir, and BM BCh.) - ↑
Master of Science
, Wikipedia. Retrieved 13 October 2021. (Latin: magisterii scientiae; also abbreviated MS, MSc, M.Sc., SM, S.M., ScM or Sc.M.) - ↑ a b
Doctor of Philosophy
, Wikipedia. Retrieved 16 June 2021. (Also abbreviated as D.Phil.)
References
- ↑ (May 2018).
WHO to develop new guidelines on male circumcision
. Retrieved 26 March 2020. - ↑
Biographies of Guideline Development Group (GDG) members for WHO guidance 
, WHO. (September 2018). Retrieved 26 March 2020.
- ↑
Mayan M, Hamilton RJ, Juurlink DN, Austin PC, Jarvi KA. Circumcision and Risk of HIV Among Males From Ontario, Canada. J Urol. 23 September 2021; PMID. DOI. Retrieved 21 August 2022.
Quote:We found that circumcision was not independently associated with the risk of acquiring HIV among men from Ontario, Canada.
- ↑ Frisch M, Simonsen J. Non-therapeutic male circumcision in infancy or childhood and risk of human immunodeficiency virus and other sexually transmitted infections: national cohort study in Denmark. Eur J Epidemiol. 26 September 2021; 37: 251–9. PMID. DOI. Retrieved 16 January 2022.
.svg){kind=icon}
